Ligandrol Magnus

Catalogue entry: Ligandrol Magnus. Labelled content: 10 mg/tablet. Listed pack: 60 tablets. The amount identifies labelled product content, not an administration dose.

Identity and mechanism

Ligandrol is the development name commonly associated with LGD-4033, a nonsteroidal androgen-receptor modulator. The SARM designation describes a research approach to separating tissue responses. It should not be read as a guarantee of muscle-only activity or freedom from endocrine effects.

What the research measured

Basaria and colleagues published a short placebo-controlled study in healthy men in the Journal of Gerontology in 2013. The investigators examined tolerability, pharmacokinetics, body composition and endocrine markers. A change in lean body mass did not establish a corresponding improvement in athletic performance, and the short observation period cannot answer long-term safety questions.

Sporting claims and limitations

Ligandrol and Ostarine are often grouped together in sporting discussions, but their studies, populations and molecular structures differ. Hormonal suppression and changes in lipid markers matter when interpreting proposed physique benefits. Regulatory SARM warnings describe serious liver and cardiovascular risks; those warnings do not supply a reliable compound-specific risk percentage for a vendor product.

Product identity and documentation

The selected option identifies the labelled content and presentation offered in this catalogue. Assess it separately from the study material. Documentation should establish LGD-4033 identity, batch traceability and an appropriate impurity profile, rather than simply repeat the marketing name. A certificate for another lot or an unspecified mixture cannot authenticate this item.